Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Research Council grant · Running

DEEPSTIM A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord Injury

Coordinator
Royal College of Surgeons in Ireland, Ireland
Runs
1 July 2025 to 31 December 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101212799

What the project is doing

In the project's own words, from its summary on CORDIS.

Spinal cord injury (SCI) can severely impact patients, impairing neurological function. The complex pathophysiology of SCI and the poor growth capacity of neurons results in a multi-faceted challenge to repair. Lifetime treatment costs for SCI patients can be as high as €2 million and approximately 11,000 new spinal cord injuries occur every year in the EU. Neuromodulation devices that provide controlled electrical stimuli to enable pain management, aid rehabilitation and represent a growing medical device market, predicted to reach an €83 Bn value by 2030.

This project proposes to combine electrical stimulation for the integration of neuromodulatory functionality with a tailored tissue engineered device to enhance regrowth of injured neurons and restore nerve function. It builds on the cutting-edge 3D-printing technologies developed during my ReCaP Advanced Grant in order to design a ground-breaking patient-specific implant for the targeted delivery of electrical stimulation to promote SCI repair.

High-resolution imaging of individual patient spinal cord injuries will facilitate 3D printing of an electroconductive implant architecture, filled with a biomimetic regenerative and immunomodulatory biomaterial, that matches both the gross lesion geometry as well as mimicking key aspects of the injured spinal axonal tract anatomy. The 3D-printed conductive architecture will be geometrically optimized to distribute externally delivered electrical stimulation to neurons throughout the injury – maximizing the therapeutic benefits of electrical stimulation.

To demonstrate proof-of-concept, DEEPSTIM will develop a prototype for preclinical testing in a rat model of SCI. The DEEPSTIM team will work with institutional commercialisation teams and seek input from clinical experts to increase the technological readiness level of the platform with the ultimate aim of forming a spin-out company to further develop the technology towards clinical translation.

Topics

Who is involved

OrganisationCityCountryRole
Royal College of Surgeons in IrelandDublin 2IrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI